Cargando…
Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
BACKGROUND: The Khorana risk score (KRS) for prognosis of venous thromboembolism (VTE) has been rarely explored in Hispanic populations. OBJECTIVE: To determine the value of the KRS for prediction of VTE and overall survival (OS) among Hispanic individuals with cancer. METHODS: We retrospectively ev...
Autores principales: | Ramos-Esquivel, Allan, Marenco-Flores, Ana, Hernández-Romero, Gabriel, Umaña-Mora, Carlos, Céspedes-Calvo, Ana, Mora-Hidalgo, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934874/ https://www.ncbi.nlm.nih.gov/pubmed/36819798 http://dx.doi.org/10.3332/ecancer.2022.1470 |
Ejemplares similares
-
Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022) -
Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021) -
Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021) -
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
por: Piver, Rachael N., et al.
Publicado: (2023) -
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)